Long-Term Benefits Following Catheter Ablation of Atrial Fibrillation

Catheter ablation has acquired a prominent role in the management of symptomatic atrial fibrillation (AF). Attempting to accurately assess the benefit of ablation can be quite challenging and is influenced by many variables, including the type of AF, procedural technique, operator experience, and du...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation Journal 2013, Vol.77(5), pp.1091-1096
Hauptverfasser: Latchamsetty, Rakesh, Morady, Fred
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1096
container_issue 5
container_start_page 1091
container_title Circulation Journal
container_volume 77
creator Latchamsetty, Rakesh
Morady, Fred
description Catheter ablation has acquired a prominent role in the management of symptomatic atrial fibrillation (AF). Attempting to accurately assess the benefit of ablation can be quite challenging and is influenced by many variables, including the type of AF, procedural technique, operator experience, and duration and method of follow-up. Equally elusive is the proper definition of a successful ablation outcome. Should a “successful” ablation necessitate complete resolution of AF and AF symptoms documented by long-term monitoring, or does a more clinical approach evaluating for symptomatic improvement constitute a favorable outcome? Furthermore, at what point following an ablation should a recurrence be an acceptable, if not an expected, occurrence and should a significant decrease in AF burden warrant consideration as success? Our goal here will be to explore the current data evaluating outcomes for ablation of AF. We will examine electrophysiologic and other clinical endpoints, and hope to provide long-term expectations following ablation of paroxysmal and persistent AF.  (Circ J 2013; 77: 1091–1096)
doi_str_mv 10.1253/circj.CJ-13-0298
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1346581628</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1346581628</sourcerecordid><originalsourceid>FETCH-LOGICAL-c595t-b4d43a90556eeb0e766d05f627757bc5e2e315b8d28fe579da3f03d30c530b4d3</originalsourceid><addsrcrecordid>eNpFkDFPwzAQhS0EoqWwM6GMLC5OHMfJWKIGqCqxlNlynEvrKo2L7Qrx70ma0i53p9P3nu4eQo8hmYYRoy9KW7Wd5gscUkyiLL1C45DGHMdpRK6Pc4KzNKYjdOfclnQIYdktGkWUxUnM6RjNl6Zd4xXYXfAKLdTau6AwTWN-dLsOcuk34MEGs7KRXps2MHUw81bLJih0aXUzrO_RTS0bBw-nPkFfxXyVv-Pl59tHPltixTLmcRlXMZXdDSwBKAnwJKkIq5OIc8ZLxSACGrIyraK0BsazStKa0IoSxSjpxHSCngffvTXfB3Be7LRT0F3Rgjk40T_M0jCJ0g4lA6qscc5CLfZW76T9FSERfXjiGJ7IF51K9OF1kqeT-6HcQXUW_KfVAcUAbJ2XazgD0nqtGjg5ci5YXy7OF2AjrYCW_gFJ7IRv</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1346581628</pqid></control><display><type>article</type><title>Long-Term Benefits Following Catheter Ablation of Atrial Fibrillation</title><source>J-STAGE Free</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Latchamsetty, Rakesh ; Morady, Fred</creator><creatorcontrib>Latchamsetty, Rakesh ; Morady, Fred</creatorcontrib><description>Catheter ablation has acquired a prominent role in the management of symptomatic atrial fibrillation (AF). Attempting to accurately assess the benefit of ablation can be quite challenging and is influenced by many variables, including the type of AF, procedural technique, operator experience, and duration and method of follow-up. Equally elusive is the proper definition of a successful ablation outcome. Should a “successful” ablation necessitate complete resolution of AF and AF symptoms documented by long-term monitoring, or does a more clinical approach evaluating for symptomatic improvement constitute a favorable outcome? Furthermore, at what point following an ablation should a recurrence be an acceptable, if not an expected, occurrence and should a significant decrease in AF burden warrant consideration as success? Our goal here will be to explore the current data evaluating outcomes for ablation of AF. We will examine electrophysiologic and other clinical endpoints, and hope to provide long-term expectations following ablation of paroxysmal and persistent AF.  (Circ J 2013; 77: 1091–1096)</description><identifier>ISSN: 1346-9843</identifier><identifier>EISSN: 1347-4820</identifier><identifier>DOI: 10.1253/circj.CJ-13-0298</identifier><identifier>PMID: 23546473</identifier><language>eng</language><publisher>Japan: The Japanese Circulation Society</publisher><subject>Ablation ; Atrial fibrillation ; Atrial Fibrillation - complications ; Atrial Fibrillation - mortality ; Atrial Fibrillation - physiopathology ; Atrial Fibrillation - surgery ; Catheter Ablation - adverse effects ; Catheter Ablation - mortality ; Humans ; Outcomes ; Recurrence ; Risk Factors ; Stroke - etiology ; Stroke - prevention &amp; control ; Thromboembolism - etiology ; Thromboembolism - prevention &amp; control ; Time Factors ; Treatment Outcome</subject><ispartof>Circulation Journal, 2013, Vol.77(5), pp.1091-1096</ispartof><rights>2013 THE JAPANESE CIRCULATION SOCIETY</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c595t-b4d43a90556eeb0e766d05f627757bc5e2e315b8d28fe579da3f03d30c530b4d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1883,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23546473$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Latchamsetty, Rakesh</creatorcontrib><creatorcontrib>Morady, Fred</creatorcontrib><title>Long-Term Benefits Following Catheter Ablation of Atrial Fibrillation</title><title>Circulation Journal</title><addtitle>Circ J</addtitle><description>Catheter ablation has acquired a prominent role in the management of symptomatic atrial fibrillation (AF). Attempting to accurately assess the benefit of ablation can be quite challenging and is influenced by many variables, including the type of AF, procedural technique, operator experience, and duration and method of follow-up. Equally elusive is the proper definition of a successful ablation outcome. Should a “successful” ablation necessitate complete resolution of AF and AF symptoms documented by long-term monitoring, or does a more clinical approach evaluating for symptomatic improvement constitute a favorable outcome? Furthermore, at what point following an ablation should a recurrence be an acceptable, if not an expected, occurrence and should a significant decrease in AF burden warrant consideration as success? Our goal here will be to explore the current data evaluating outcomes for ablation of AF. We will examine electrophysiologic and other clinical endpoints, and hope to provide long-term expectations following ablation of paroxysmal and persistent AF.  (Circ J 2013; 77: 1091–1096)</description><subject>Ablation</subject><subject>Atrial fibrillation</subject><subject>Atrial Fibrillation - complications</subject><subject>Atrial Fibrillation - mortality</subject><subject>Atrial Fibrillation - physiopathology</subject><subject>Atrial Fibrillation - surgery</subject><subject>Catheter Ablation - adverse effects</subject><subject>Catheter Ablation - mortality</subject><subject>Humans</subject><subject>Outcomes</subject><subject>Recurrence</subject><subject>Risk Factors</subject><subject>Stroke - etiology</subject><subject>Stroke - prevention &amp; control</subject><subject>Thromboembolism - etiology</subject><subject>Thromboembolism - prevention &amp; control</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>1346-9843</issn><issn>1347-4820</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkDFPwzAQhS0EoqWwM6GMLC5OHMfJWKIGqCqxlNlynEvrKo2L7Qrx70ma0i53p9P3nu4eQo8hmYYRoy9KW7Wd5gscUkyiLL1C45DGHMdpRK6Pc4KzNKYjdOfclnQIYdktGkWUxUnM6RjNl6Zd4xXYXfAKLdTau6AwTWN-dLsOcuk34MEGs7KRXps2MHUw81bLJih0aXUzrO_RTS0bBw-nPkFfxXyVv-Pl59tHPltixTLmcRlXMZXdDSwBKAnwJKkIq5OIc8ZLxSACGrIyraK0BsazStKa0IoSxSjpxHSCngffvTXfB3Be7LRT0F3Rgjk40T_M0jCJ0g4lA6qscc5CLfZW76T9FSERfXjiGJ7IF51K9OF1kqeT-6HcQXUW_KfVAcUAbJ2XazgD0nqtGjg5ci5YXy7OF2AjrYCW_gFJ7IRv</recordid><startdate>2013</startdate><enddate>2013</enddate><creator>Latchamsetty, Rakesh</creator><creator>Morady, Fred</creator><general>The Japanese Circulation Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2013</creationdate><title>Long-Term Benefits Following Catheter Ablation of Atrial Fibrillation</title><author>Latchamsetty, Rakesh ; Morady, Fred</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c595t-b4d43a90556eeb0e766d05f627757bc5e2e315b8d28fe579da3f03d30c530b4d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Ablation</topic><topic>Atrial fibrillation</topic><topic>Atrial Fibrillation - complications</topic><topic>Atrial Fibrillation - mortality</topic><topic>Atrial Fibrillation - physiopathology</topic><topic>Atrial Fibrillation - surgery</topic><topic>Catheter Ablation - adverse effects</topic><topic>Catheter Ablation - mortality</topic><topic>Humans</topic><topic>Outcomes</topic><topic>Recurrence</topic><topic>Risk Factors</topic><topic>Stroke - etiology</topic><topic>Stroke - prevention &amp; control</topic><topic>Thromboembolism - etiology</topic><topic>Thromboembolism - prevention &amp; control</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Latchamsetty, Rakesh</creatorcontrib><creatorcontrib>Morady, Fred</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation Journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Latchamsetty, Rakesh</au><au>Morady, Fred</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-Term Benefits Following Catheter Ablation of Atrial Fibrillation</atitle><jtitle>Circulation Journal</jtitle><addtitle>Circ J</addtitle><date>2013</date><risdate>2013</risdate><volume>77</volume><issue>5</issue><spage>1091</spage><epage>1096</epage><pages>1091-1096</pages><issn>1346-9843</issn><eissn>1347-4820</eissn><abstract>Catheter ablation has acquired a prominent role in the management of symptomatic atrial fibrillation (AF). Attempting to accurately assess the benefit of ablation can be quite challenging and is influenced by many variables, including the type of AF, procedural technique, operator experience, and duration and method of follow-up. Equally elusive is the proper definition of a successful ablation outcome. Should a “successful” ablation necessitate complete resolution of AF and AF symptoms documented by long-term monitoring, or does a more clinical approach evaluating for symptomatic improvement constitute a favorable outcome? Furthermore, at what point following an ablation should a recurrence be an acceptable, if not an expected, occurrence and should a significant decrease in AF burden warrant consideration as success? Our goal here will be to explore the current data evaluating outcomes for ablation of AF. We will examine electrophysiologic and other clinical endpoints, and hope to provide long-term expectations following ablation of paroxysmal and persistent AF.  (Circ J 2013; 77: 1091–1096)</abstract><cop>Japan</cop><pub>The Japanese Circulation Society</pub><pmid>23546473</pmid><doi>10.1253/circj.CJ-13-0298</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1346-9843
ispartof Circulation Journal, 2013, Vol.77(5), pp.1091-1096
issn 1346-9843
1347-4820
language eng
recordid cdi_proquest_miscellaneous_1346581628
source J-STAGE Free; MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Ablation
Atrial fibrillation
Atrial Fibrillation - complications
Atrial Fibrillation - mortality
Atrial Fibrillation - physiopathology
Atrial Fibrillation - surgery
Catheter Ablation - adverse effects
Catheter Ablation - mortality
Humans
Outcomes
Recurrence
Risk Factors
Stroke - etiology
Stroke - prevention & control
Thromboembolism - etiology
Thromboembolism - prevention & control
Time Factors
Treatment Outcome
title Long-Term Benefits Following Catheter Ablation of Atrial Fibrillation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T08%3A32%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-Term%20Benefits%20Following%20Catheter%20Ablation%20of%20Atrial%20Fibrillation&rft.jtitle=Circulation%20Journal&rft.au=Latchamsetty,%20Rakesh&rft.date=2013&rft.volume=77&rft.issue=5&rft.spage=1091&rft.epage=1096&rft.pages=1091-1096&rft.issn=1346-9843&rft.eissn=1347-4820&rft_id=info:doi/10.1253/circj.CJ-13-0298&rft_dat=%3Cproquest_cross%3E1346581628%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1346581628&rft_id=info:pmid/23546473&rfr_iscdi=true